tradingkey.logo

Evoke Pharma Inc <EVOK.OQ> expected to post a loss of 63 cents a share - Earnings Preview

ReutersMar 11, 2025 8:20 PM
  • Evoke Pharma Inc EVOK.OQ EVOK.O is expected to show a rise in quarterly revenue when it reports results on March 13 for the period ending December 31 2024

  • The Solana Beach California-based company is expected to report a 84.0% increase in revenue to $3.084 million from $1.68 million a year ago, according to the estimate from one analyst, based on LSEG data.

  • ​LSEG's mean analyst estimate for Evoke Pharma Inc is for a loss of 63 cents per share.

  • The one available analyst rating on the shares is "buy".

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

  • Wall Street's median 12-month price target for Evoke Pharma Inc is $18.00​, above​ its last closing price of $3.76. ​​​

This summary was machine generated March 11 at 20:20 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI